Home > Healthcare > Medical Devices > Therapeutic Devices > Femtech Market

Femtech Market Size

  • Report ID: GMI4442
  • Published Date: Dec 2022
  • Report Format: PDF

Femtech Market Size

Femtech Market size crossed USD 30 billion in 2022 and is poised to depict over 16% CAGR through 2023-2032. This is a result of the escalating adoption of digitized healthcare solutions and the mounting health burden in underdeveloped regions.


With rapid digitalization, femtech is emerging as a prominent trend in the health sector that helps meet the unmet health needs of women. Health tech service providers have been emphasizing the development of advanced devices for minimally invasive and non-invasive procedures. In addition, the rising development of tech-enabled products for improved diagnosis and clinical information delivery will boost the popularity of femtech devices.


Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for femtech exceeded USD 30 billion in 2022 and is poised to depict over 16% CAGR through 2023-2032, due to the escalating adoption of digitized healthcare solutions.

Services type segment will register a 15% CAGR through 2023-2032, as a result of the rising fertility rate and virtual health platform adoption.

Europe femtech market is anticipated to cross USD 35 billion by 2032, due to mounting government health spending and medical manufacturing expansion.

BioWink GmbH, Athena Feminine Technologies, Conceivable, Inc, HeraMED, Elvie, iSono Health, Nuvo Cares, Minerva Surgical, Prelude, Sustain Natural, Sera Prognostics, Univfy, and Totohealth are among the key players operating in the market.

Femtech Market Scope

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 193
  • Countries covered: 16
  • Pages: 145
 Download Free Sample